about
Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Gluco-incretins regulate beta-cell glucose competence by epigenetic silencing of Fxyd3 expressionOverexpression of FXYD-3 is involved in the tumorigenesis and development of esophageal squamous cell carcinoma.Ion channels expression and function are strongly modified in solid tumors and vascular malformations
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@ast
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@en
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@nl
type
label
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@ast
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@en
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@nl
prefLabel
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@ast
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@en
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
FXYD3: A Promising Biomarker for Urothelial Carcinoma.
@en
P2093
Bill Wondergem
Cheng-Keng Chuang
Chunyan Luan
Katherine A Kasper
See-Tong Pang
Ximing J Yang
Zhongfa Zhang
P2860
P356
10.4137/BMI.S6487
P50
P577
2011-02-15T00:00:00Z